Showing results (31-40 of 456) with videos related to
Sort By:
Pageof 46
Current Protocols in Mouse Biology|November 30, 2018
Adeno-Associated Virus Production, Purification, and TiteringYong Hong Chen, Megan S Keiser, Beverly L DavidsonMolecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2018
Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene TherapyYonghong Chen, Shujuan Zheng, Luis Tecedor, et al.Neuroscience Letters|October 30, 2003
Transduction of neurons lining the cerebral external capsules in mice with feline immunodeficiency virus based vectorsJoseph M Alisky, Stephanie M Hughes, Beverly L DavidsonThe Journal of Gene Medicine|September 11, 2002
Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injectionTodd A Derksen, Sybille L Sauter, Beverly L DavidsonHuman Molecular Genetics|November 16, 2013
Functional microRNAs and target sites are created by lineage-specific transpositionRyan M Spengler, Clayton K Oakley, Beverly L DavidsonMolecular Therapy. Nucleic Acids|May 1, 2013
Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain StructureJames C Geoghegan, Brian L Gilmore, Beverly L DavidsonRNA (New York, N.Y.)|August 14, 2008
Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAsRyan L Boudreau, Alex Mas Monteys, Beverly L DavidsonMolecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2014
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapyMegan S Keiser, Ryan L Boudreau, Beverly L DavidsonNature Biotechnology|September 24, 2002
siRNA-mediated gene silencing in vitro and in vivoHaibin Xia, Qinwen Mao, Henry L Paulson, et al.FEBS Letters|April 23, 2003
Membrane topology of CLN3, the protein underlying Batten diseaseQinwen Mao, Brian J Foster, Haibin Xia, et al.Pageof 46